Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carboplatin and Radiotherapy for Newly Diagnosed Ependymoma
NCT01088035Phase 2Terminated
- Sponsor
- Ann & Robert H Lurie Children's Hospital of Chicago
- Start
- Apr 2010
- Primary completion
- Jan 2015
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of carboplatin in ependymoma, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago. Started Apr 2010; status: terminated.
02
Drugs
carboplatin
03
Conditions
ependymoma
Beyond the preview
Go deeper on NCT01088035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01088035.